BioLineRx, Hadasit Announces Collaboration

News   Aug 04, 2016

 
BioLineRx, Hadasit Announces Collaboration
 
 
 

RELATED ARTICLES

Symmetry-breaking Method Opens Way for Bioactive Compounds

News

EPFL chemists have developed a new catalytic method for symmetry breaking. Published in Angewandte Chemie, the method can help synthesize important building blocks for bioactive compounds such as anticancer drugs.

READ MORE

Investigational Drug for Melanoma Shows Promise in Early-Stage Study

News

An investigational compound designed to block a hyperactive cell growth signal in advanced melanoma and other cancers has shown some promise in an early-stage clinical trial researchers have reported.

READ MORE

‘Mini Tumors’ from Patient Samples Could Help Personalize Cancer Drug Treatment

News

Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tell in advance which treatments will work, a major new study reports.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE